(Q44405507)

2 December 2017

Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. (English)

1 reference

2 December 2017

0 references

1 reference

1

1 reference

2 December 2017

Adrie W Bruijnzeel

2

1 reference

PubMed ID

12698231

2 December 2017

Karen L Skjei

series ordinal

3

1 reference

PubMed ID

12698231

2 December 2017

Athina Markou

series ordinal

4

1 reference

2 December 2017

16 April 2003

1 reference

2 December 2017

1 reference

2 December 2017

168

1 reference

2 December 2017

3

1 reference

2 December 2017

347-358

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-003-1445-7

2 December 2017

0 references

cites work

Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents

1 reference

12 December 2020

Postcocaine anhedonia. An animal model of cocaine withdrawal.

1 reference

12 December 2020

Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat--interactions between the two drugs.

1 reference

12 December 2020

Dissociation of dopamine release in the nucleus accumbens from intracranial self-stimulation.

1 reference

12 December 2020

Rodent model of nicotine abstinence syndrome

1 reference

12 December 2020

Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects.

1 reference

12 December 2020

Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats

1 reference

12 December 2020

Dramatic decreases in brain reward function during nicotine withdrawal.

1 reference

12 December 2020

Desmethylimipramine attenuates cocaine withdrawal in rats

1 reference

12 December 2020

Pharmacologic treatments for the nicotine dependent smoker.

1 reference

12 December 2020

A prescription to resist proscriptions for murine models of depression

1 reference

12 December 2020

A reward-reduction model of depression using self stimulating rats: An appraisal

1 reference

12 December 2020

Smoking and mental illness

1 reference

12 December 2020

Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories

1 reference

12 December 2020

Intracranial reward after Lilly 110140 (fluoxetine HCl): Evidence for an inhibitory role for serotonin

1 reference

12 December 2020

A 'crash' course on psychostimulant withdrawal as a model of depression

1 reference

12 December 2020

Serotonin-1A antagonists attenuate the effects of nicotine withdrawal on the auditory startle response

1 reference

12 December 2020

Clozapine treatment attenuated somatic and affective signs of nicotine and amphetamine withdrawal in subsets of rats exhibiting hyposensitivity to the initial effects of clozapine

1 reference

12 December 2020

The scientific case that nicotine is addictive.

1 reference

12 December 2020

Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas

1 reference

12 December 2020

Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats

1 reference

12 December 2020

Mortality from tobacco in developed countries: indirect estimation from national vital statistics.

1 reference

12 December 2020

Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics.

1 reference

12 December 2020

Catecholamines and self-stimulation: Evidence suggesting a reinforcing role for noradrenaline and a motivating role for dopamine

1 reference

12 December 2020

Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial

1 reference

12 December 2020

Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial.

1 reference

12 December 2020

Bupropion occupancy of the dopamine transporter is low during clinical treatment.

1 reference

12 December 2020

Depression and nicotine: preclinical and clinical evidence for common mechanisms

1 reference

12 December 2020

The dorsal raphé nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses.

1 reference

12 December 2020

Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine

1 reference

12 December 2020

Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis

1 reference

12 December 2020

Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine

1 reference

12 December 2020

Nicotine and bupropion share a similar discriminative stimulus effect

1 reference

12 December 2020

Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial

1 reference

12 December 2020

Nicotine-like discriminative stimulus effects of bupropion in rats

1 reference

12 December 2020

Amphetamine and the reward system: Evidence for tolerance and post-drug depression

1 reference

12 December 2020

Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.

1 reference

12 December 2020

Mediating mechanisms for the impact of bupropion in smoking cessation treatment

1 reference

12 December 2020

The pharmacology underlying pharmacotherapy for tobacco dependence: a focus on bupropion.

1 reference

12 December 2020

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

1 reference

12 December 2020

Depression and the dynamics of smoking. A national perspective

1 reference

12 December 2020

Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats

1 reference

12 December 2020

Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults

1 reference

12 December 2020

Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism

1 reference

12 December 2020

Neurobiological similarities in depression and drug dependence: a self-medication hypothesis

1 reference

12 December 2020

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

1 reference

12 December 2020

Acute and chronic desipramine treatment effects on rewarding electrical stimulation of the lateral hypothalamus.

1 reference

12 December 2020

A placebo controlled trial of bupropion for smoking cessation in schizophrenia

1 reference

12 December 2020

Mouse models for psychiatric disorders.

1 reference

12 December 2020

Personality measures as predictors of smoking initiation and cessation in the UNC Alumni Heart Study.

1 reference

12 December 2020

Assessing antidepressant activity in rodents: recent developments and future needs

1 reference

12 December 2020

Major depression and stages of smoking. A longitudinal investigation

1 reference

12 December 2020

Smoking, smoking cessation, and major depression

1 reference

12 December 2020

Specific inhibition of hypothalamic self-stimulation by selective reuptake blockade of either 5-hydroxytryptamine or noradrenaline

1 reference

12 December 2020

Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats

1 reference

12 December 2020

The effect of bupropion on nicotine craving and withdrawal.

1 reference

12 December 2020

Nicotine dependence: studies with a laboratory model

1 reference

12 December 2020

Bupropion: a review of its mechanism of antidepressant activity.

1 reference

12 December 2020

Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs

1 reference

12 December 2020

A comparison of sustained-release bupropion and placebo for smoking cessation

1 reference

12 December 2020

Euphorigenic drugs: effects on the reward pathways of the brain

1 reference

12 December 2020

Symptoms of tobacco withdrawal. A replication and extension.

1 reference

12 December 2020

Effects of long-term cigarette smoking on the human locus coeruleus

1 reference

12 December 2020

Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone

1 reference

12 December 2020

Recent advances in the pharmacotherapy of smoking

1 reference

12 December 2020

Acute and chronic fluoxetine treatment decreases the sensitivity of rats to rewarding brain stimulation.

1 reference

12 December 2020

Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections

1 reference

12 December 2020

The effects of long-term administration of antidepressant drugs on intracranial self-stimulation responding in rats

1 reference

12 December 2020

Effect of nonnicotine pharmacotherapy on smoking behavior

1 reference

12 December 2020

Bupropion is a nicotinic antagonist.

1 reference

12 December 2020

Construct validity of a self-stimulation threshold paradigm: Effects of reward and performance manipulations

1 reference

12 December 2020

Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: role of nicotinic receptors in the ventral tegmental area.

1 reference

12 December 2020

Facilitation of Brain Self-Stimulation by Central Administration of Norepinephrine

1 reference

12 December 2020

The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.

1 reference

12 December 2020

Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment

1 reference

12 December 2020

10.1007/S00213-003-1445-7

Identifiers

DOI

1 reference

2 December 2017

1 reference

PubMed ID

12698231